—

venBio Partners LLC

Q1 2026 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    6

  • Value ($000)

    $280,553

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001776382
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

PHARVARIS N V

COM
N69605108
$131.06M
47 %

4,639,304

A
ALMS

ALUMIS INC

COM
022307102
$99.76M
36 %

4,528,408

A
ALXO

ALX ONCOLOGY HLDGS INC

COM
00166B105
$25.83M
9 %

12,884,638

H
HRMY

HARMONY BIOSCIENCES HLDGS IN

COM
413197104
$13.7M
5 %

489,194

---

LYELL IMMUNOPHARMA INC

COM
55083R203
$6.77M
2 %

337,697

---

ARTIVA BIOTHERAPEUTICS INC

COM
04317A107
$3.42M
1 %

531,337

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6